103 related articles for article (PubMed ID: 29445192)
1. SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma.
Saini M; Verma A; Mathew SJ
Cell Death Dis; 2018 Feb; 9(2):237. PubMed ID: 29445192
[TBL] [Abstract][Full Text] [Related]
2. DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.
Megiorni F; Camero S; Ceccarelli S; McDowell HP; Mannarino O; Marampon F; Pizer B; Shukla R; Pizzuti A; Marchese C; Clerico A; Dominici C
Oncotarget; 2016 Nov; 7(48):79342-79356. PubMed ID: 27764816
[TBL] [Abstract][Full Text] [Related]
3. NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma.
Tombolan L; Poli E; Martini P; Zin A; Romualdi C; Bisogno G; Lanfranchi G
Oncotarget; 2017 May; 8(20):33086-33099. PubMed ID: 28380437
[TBL] [Abstract][Full Text] [Related]
4. Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.
Pomella S; Sreenivas P; Gryder BE; Wang L; Milewski D; Cassandri M; Baxi K; Hensch NR; Carcarino E; Song Y; Chou HC; Yohe ME; Stanton BZ; Amadio B; Caruana I; De Stefanis C; De Vito R; Locatelli F; Chen Y; Chen EY; Houghton P; Khan J; Rota R; Ignatius MS
Nat Commun; 2021 Jan; 12(1):192. PubMed ID: 33420019
[TBL] [Abstract][Full Text] [Related]
5. Novel small molecule DMAMCL induces differentiation in rhabdomyosarcoma by downregulating of DLL1.
Li Q; Chen Y; Chen Y; Hua Z; Gong B; Liu Z; Thiele CJ; Li Z
Biomed Pharmacother; 2024 May; 174():116562. PubMed ID: 38626518
[TBL] [Abstract][Full Text] [Related]
6. CD73 contributes to the pathogenesis of fusion-negative rhabdomyosarcoma through the purinergic signaling pathway.
Hernandez KC; Shah AM; Lopez VA; Tagliabracci VS; Chen K; Xu L; Bassel-Duby R; Olson EN; Liu N
Proc Natl Acad Sci U S A; 2024 Jan; 121(4):e2315925121. PubMed ID: 38227654
[TBL] [Abstract][Full Text] [Related]
7. Sensitization to Ionizing Radiation by MEK Inhibition Is Dependent on SNAI2 in Fusion-Negative Rhabdomyosarcoma.
Hensch NR; Bondra K; Wang L; Sreenivas P; Zhao XR; Modi P; Vaseva AV; Houghton PJ; Ignatius MS
Mol Cancer Ther; 2023 Jan; 22(1):123-134. PubMed ID: 36162055
[TBL] [Abstract][Full Text] [Related]
8. Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization.
Petragnano F; Pietrantoni I; Camero S; Codenotti S; Milazzo L; Vulcano F; Macioce G; Giordani I; Tini P; Cheleschi S; Gravina GL; Festuccia C; Rossetti A; Delle Monache S; Ordinelli A; Ciccarelli C; Mauro A; Barbara B; Antinozzi C; Schiavetti A; Maggio R; Di Luigi L; Polimeni A; Marchese C; Tombolini V; Fanzani A; Bernabò N; Megiorni F; Marampon F
J Biomed Sci; 2020 Aug; 27(1):90. PubMed ID: 32854690
[TBL] [Abstract][Full Text] [Related]
9. Single-cell analysis and functional characterization uncover the stem cell hierarchies and developmental origins of rhabdomyosarcoma.
Wei Y; Qin Q; Yan C; Hayes MN; Garcia SP; Xi H; Do D; Jin AH; Eng TC; McCarthy KM; Adhikari A; Onozato ML; Spentzos D; Neilsen GP; Iafrate AJ; Wexler LH; Pyle AD; Suvà ML; Dela Cruz F; Pinello L; Langenau DM
Nat Cancer; 2022 Aug; 3(8):961-975. PubMed ID: 35982179
[TBL] [Abstract][Full Text] [Related]
10. Smyd1: Implications for novel approaches in rhabdomyosarcoma therapy.
Berkholz J; Schmitt A; Fragasso A; Schmid AC; Munz B
Exp Cell Res; 2024 Jan; 434(2):113863. PubMed ID: 38097153
[TBL] [Abstract][Full Text] [Related]
11. TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling.
Ye J; Liu W; Yu X; Wu L; Chen Z; Yu Y; Wang J; Bai S; Zhang M
Cell Death Discov; 2023 Oct; 9(1):378. PubMed ID: 37845209
[TBL] [Abstract][Full Text] [Related]
12. Receptor tyrosine kinase gene expression profiling of orbital rhabdomyosarcoma unveils MET as a potential biomarker and therapeutic target.
Chauhan S; Sen S; Irshad K; Kashyap S; Pushker N; Meel R; Sharma MC
Hum Cell; 2024 Jan; 37(1):297-309. PubMed ID: 37914903
[TBL] [Abstract][Full Text] [Related]
13. Characterization of GRK5 as a novel regulator of rhabdomyosarcoma tumor cell growth and self-renewal.
Pham T; Robinson K; Vleeshouwer-Neumann T; Annis JE; Chen EY
Oncotarget; 2020 Apr; 11(16):1448-1461. PubMed ID: 32363002
[TBL] [Abstract][Full Text] [Related]
14. Developmental Heterogeneity of Rhabdomyosarcoma.
Stevens BT; Hatley ME
Cold Spring Harb Perspect Med; 2024 May; ():. PubMed ID: 38772705
[TBL] [Abstract][Full Text] [Related]
15. The Wnt-pathway corepressor TLE3 interacts with the histone methyltransferase KMT1A to inhibit differentiation in Rhabdomyosarcoma.
Kalita B; Sahu S; Bharadwaj A; Panneerselvam L; Martinez-Cebrian G; Agarwal M; Mathew SJ
Oncogene; 2024 Feb; 43(7):524-538. PubMed ID: 38177411
[TBL] [Abstract][Full Text] [Related]
16. Targeting exosomes enveloped EBV-miR-BART1-5p-antagomiRs for NPC therapy through both anti-vasculogenic mimicry and anti-angiogenesis.
Wang J; Liu Y; Zhang Y; Li X; Fang M; Qian D
Cancer Med; 2023 Jun; 12(11):12608-12621. PubMed ID: 37097161
[TBL] [Abstract][Full Text] [Related]
17. PKD phosphorylation and COP9/Signalosome modulate intracellular Spry2 protein stability.
Martínez N; Gragera T; de Lucas MP; Cámara AB; Ballester A; Anta B; Fernández-Medarde A; López-Briones T; Ortega J; Peña-Jiménez D; Barbáchano A; Montero-Calle A; Cordero V; Barderas R; Iglesias T; Yunta M; Oliva JL; Muñoz A; Santos E; Zarich N; Rojas-Cabañeros JM
Oncogenesis; 2023 Apr; 12(1):20. PubMed ID: 37045830
[TBL] [Abstract][Full Text] [Related]
18. Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis.
Li Y; Li D; Wang J; Tang J
Diagn Pathol; 2023 Mar; 18(1):41. PubMed ID: 36998041
[TBL] [Abstract][Full Text] [Related]
19. Non-coding RNA in rhabdomyosarcoma progression and metastasis.
Ramadan F; Saab R; Hussein N; Clézardin P; Cohen PA; Ghayad SE
Front Oncol; 2022; 12():971174. PubMed ID: 36033507
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]